Bulgarians, Italians to Develop Anti-AIDS Vaccine for Newborns
April 6, 2006
Bulgarian and Italian researchers announced Wednesday they are collaborating on the development of an AIDS vaccine, based on a Bulgarian TB vaccine for infants, that will target African newborns who are infected with HIV through breastfeeding. "We signed an agreement with our Italian colleagues to jointly develop an anti-HIV vaccine based on the Bulgarian BCG vaccine," said Bogdan Petrunov, head of the Institute for Communicable Diseases in Sofia. "Our approach is to combine a neonatal AIDS vaccine with the BCG, the first vaccine given to newborn babies after birth and a very good immunity stimulant," said professor Vittorio Colizzi of Tor Vergata University in Rome. "In the past two years we have already studied the possibility to recombine the BCG vaccine by adding HIV proteins to it. We have also successfully isolated those HIV peptides," Colizzi added. It is not known how long the vaccine development process will take.
Agence France Presse
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.